Disease Browser
|
Parent Node: Autoimmune Diseases (D001327) | Parent Node: Vitiligo (D014820) | ..Starting node ..VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (OMIM:606579)
| Child Nodes:
|
Sister Nodes: | ..Alopecia universalis onychodystrophy vitiligo (C537056)
| ..AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 1 (OMIM:607836)
| ..AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 2 (OMIM:608391)
| ..AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 3 (OMIM:608392)
| ..AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 4 (OMIM:609400)
| ..Deafness, Congenital, with Vitiligo and Achalasia (C565642)
| ..Schrander-Stumpel Theunissen Hulsmans syndrome (C536639)
| ..Spastic paraplegia 23 (C536859)
| ..Vitiligo, Progressive, with Mental Retardation and Urethral Duplication (C564739)
| ..VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (OMIM:606579)
| ..VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 6 (OMIM:193200)
|
Human Disease MESH is developed by UMLS. Further data from MedGen, OMIM, CTD
|
|
|
Term ID: | 11640 |
Name: | VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 |
Definition: | |
Alternative IDs: | |
ParentIDs: | MESH:D001327|MESH:D014820 |
TreeNumbers: | C17.800.621.440.895/606579 |C20.111/606579 |
Synonyms: | SLEV1 |SYSTEMIC LUPUS ERYTHEMATOSUS, VITILIGO-RELATED |VAMAS1 |VITILIGO |VTLG |
Slim Mappings: | Immune system disease|Skin disease |
Reference: |
MedGen: 606579
MeSH: 606579
OMIM: 606579;
Genes: NLRP1; | Phenotypes | | Disease Causing ClinVar Variants | Variation_Name | GeneID | GeneSymbol | ClinicalSignificance | dbSNP | RCVaccession | TestedInGTR | PhenotypeIDs | Chromosome | Start | Stop | HGVS_c | HGVS_p | HGVS_g | OtherIDs | Disease_ClinVar | Disease_hgmd | NM_001033053.2(NLRP1):c.464T>A (p.Leu155His) | 22861 | NLRP1 | risk factor | 12150220 | RCV000004380; | N | MedGen:C1847835,OMIM:606579 | 17 | 5485367 | 5485367 | NM_001033053.2:c.464T>A | NP_001028225.1:p.Leu155His | NC_000017.10:g.5485367A>T | OMIM Allelic Variant:606636.0001 | C1847835 606579 Vitiligo-associated multiple autoimmune disease susceptibility 1 | | |
|
|